2SLGBTQIA+ Patient & Public Advisory Team for Equity, Diversity & Inclusion in Organ Donation and Transplantation in Canada

Study Lead

Dr. Murdoch Leeies

University of Manitoba


Dr. Murdoch Leeies‘ team at University of Manitoba is forming a 2SLGBTQIA+ patient/family advisory team and is looking for interested people who have been involved with the organ donation or transplantation system. If you are a 2SLGBTQIA+ identifying person who has been a living organ donor, a solid organ transplant recipient or the substitute-decision maker or caregiver of a 2SLGBTQIA+ person who was considered for donation after death (whether they did or did not donate) then they hope you will consider registering your interest to participate.

The team hopes that your engagement will help them to design research as well as policies that can improve equity for 2SLGBTQIA+ people in our health system. We greatly value your participation.

Type of Participation

Patient Partnership




All provinces and territories

Related studies

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024

  • Resources to Improve Acute Kidney Injury Care

    Overview: Have you or someone you know experienced acute kidney injury (AKI) ? We would like to get your feedback on resources we have developed for both patients and family physicians to improve AKI care. The resources include a patient flyer, a webpage on AKI, and a discharge summary.

    Study type: Focus Group, Interview

    June 20, 2024

  • Rural-to-Urban Relocation for Organ Transplants in British Columbia: Patient Experience and Cost

    Overview: The purpose of this study is to develop an understanding of the out-of-pocket costs of rural solid organ transplant patients from British Columbia and their caregivers coming to Vancouver for transplant care to support advocacy efforts.

    Study type: Interview, Survey

    June 13, 2024